|
| 37665776 | Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group. | Neuro Oncol | 2024 |
| 35961053 | Prognostic validation of a new classification system for extent of resection in glioblastoma: AÂ report of the RANO resect group. | Neuro Oncol | 2023 |
| 36952585 | TERT Immunohistochemistry as a Surrogate Marker for TERT Promoter Mutations in Infiltrating Gliomas. | Appl Immunohistochem Mol Morphol | 2023 |
| 37253096 | Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group. | Neuro Oncol | 2023 |
| 37018650 | Prediction of Brain Metastases Development in Patients With Lung Cancer by Explainable Artificial Intelligence From Electronic Health Records. | JCO Clin Cancer Inform | 2023 |
| 36841851 | Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases. | Sci Rep | 2023 |
| 36530080 | Infiltrating gliomas with FGFR alterations: Histologic features, genetic alterations, and potential clinical implications. | Cancer Biomark | 2023 |
| 34997451 | Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma. | J Neurooncol | 2022 |
| 35364590 | Early repeat resection for residual glioblastoma: decision-making among an international cohort of neurosurgeons. | J Neurosurg | 2022 |
| 35816267 | IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas. | J Neurooncol | 2022 |
| 35591978 | Glioma and the gut-brain axis: opportunities and future perspectives. | Neurooncol Adv | 2022 |
| 36106886 | Commentary: Predictors and Impact of Postoperative 30-Day Readmission in Glioblastoma. | Neurosurgery | 2022 |
| 36351333 | BRAF/MEK Dual Inhibitors Therapy in Progressive and Anaplastic Pleomorphic Xanthoastrocytoma: Case Series and Literature Review. | J Natl Compr Canc Netw | 2022 |
| 36325373 | <i>TERT</i> promotor status does not add prognostic information in <i>IDH</i>-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO <i>resect</i> group. | Neurooncol Adv | 2022 |
| 35123024 | Metastatic Neoplasm Volume Kinetics Following 2-Stage Stereotactic Radiosurgery. | World Neurosurg | 2022 |
| 35179134 | Molecular, Histological, and Clinical Characteristics of Oligodendrogliomas: A Multi-Institutional Retrospective Study. | Neurosurgery | 2022 |
| 33481149 | Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes? | J Neurooncol | 2021 |
| 33881725 | PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma. | J Neurooncol | 2021 |
| 33826714 | Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma. | Neurosurgery | 2021 |
| 33492602 | Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma. | J Neurooncol | 2021 |
| 33492489 | IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions. | Curr Oncol Rep | 2021 |
| 33516867 | Role of Ethnicity and Geographic Location on Glioblastoma IDH1/IDH2 Mutations. | World Neurosurg | 2021 |
| 33531134 | Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies. | J Mol Diagn | 2021 |
| 34863438 | Hormone exposure and its suppressive effect on risk of high-grade gliomas among patients with breast cancer. | J Clin Neurosci | 2021 |
| 34492549 | Geographic landscape of foreign medical graduates in US neurosurgery training programs from 2007 to 2017. | Clin Neurol Neurosurg | 2021 |
| 34131647 | The role of <i>RB1</i> alteration and 4q12 amplification in IDH-WT glioblastoma. | Neurooncol Adv | 2021 |
| 34320218 | A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma. | Neurosurgery | 2021 |
| 33171326 | Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter? | World Neurosurg | 2021 |
| 33369669 | Differences in Genomic Alterations Between Brain Metastases and Primary Tumors. | Neurosurgery | 2021 |
| 33454497 | Extent of resection and survival outcomes of geriatric patients with glioblastoma: Is there benefit from aggressive surgery? | Clin Neurol Neurosurg | 2021 |
| 33300867 | Variable expression of CXCR4 in molecular subtypes of infiltrating gliomas. | Clin Neuropathol | 2021 |
| 32298823 | Increased Risk of Subsequent Meningioma Among Women with Malignant Breast Cancer. | World Neurosurg | 2020 |
| 35402955 | Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation. | IEEE Open J Eng Med Biol | 2020 |
| 33898055 | Predictors of outcome in pleomorphic xanthoastrocytoma. | Neurooncol Pract | 2020 |
| 32033906 | Corrigendum to 'Hemicraniectomy for Supratentorial Primary Intracerebral Hemorrhage: A Retrospective, Propensity Score Matched Study' [Journal of Stroke and Cerebrovascular Diseases, Vol. 28, No. 11 (November), 2019: 104361]. | J Stroke Cerebrovasc Dis | 2020 |
| 33161322 | Real-time intracranial pressure monitoring during high-dose methotrexate treatment for primary central nervous system lymphoma. | Cancer Treat Res Commun | 2020 |
| 33273497 | Glioma and temozolomide induced alterations in gut microbiome. | Sci Rep | 2020 |
| 33045626 | Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location. | Clin Neurol Neurosurg | 2020 |
| 33317715 | Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics. | J Clin Neurosci | 2020 |
| 32602743 | Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters. | CNS Oncol | 2020 |
| 32770097 | NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways. | Sci Rep | 2020 |
| 32797954 | Letter to the Editor Regarding "The Path to U.S. Neurosurgical Residency for Foreign Medical Graduates: Trends from a Decade 2007-2017". | World Neurosurg | 2020 |
| 33014393 | Geographic and socioeconomic considerations for glioblastoma treatment in the elderly at a national level: a US perspective. | Neurooncol Pract | 2020 |
| 32868820 | Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors. | Sci Rep | 2020 |
| 32949797 | The Brain is Not Flat: Conformal Electrode Arrays Diminish Complications of Subdural Electrode Implantation, A Series of 117 Cases. | World Neurosurg | 2020 |
| 33009979 | Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses. | J Neurooncol | 2020 |
| 33008831 | Ion Channels and Their Role in the Pathophysiology of Gliomas. | Mol Cancer Ther | 2020 |
| 32365205 | Endoscopic Third Ventriculostomy for Hydrocephalus Secondary to Extraventricular Obstruction in Thalamic Hemorrhage: A Case Series. | Oper Neurosurg (Hagerstown) | 2020 |
| 32278940 | A direct visuosensory cortical connectivity of the human limbic system. Dissecting the trajectory of the parieto-occipito-hypothalamic tract in the human brain using diffusion weighted tractography. | Neurosci Lett | 2020 |
| 32440969 | Molecular characteristics and clinical features of multifocal glioblastoma. | J Neurooncol | 2020 |